Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Apogee Therapeutics, Inc. | APGE | 987K | $131M |
Relay Therapeutics, Inc. | RLAY | 1.05M | $19.65M |
Alkermes plc | ALKS | 1.13M | $58.94M |
Spyre Therapeutics, Inc. | SYRE | 1.28M | $113.56M |
Xenon Pharmaceuticals Inc. | XENE | 1.59M | $96.27M |
Trevi Therapeutics, Inc. | TRVI | 1.8M | $33.57M |
First Tracks Biotherapeutics Inc | TRAX | 2.03M | $40.88M |
Roivant Sciences Ltd. | ROIV | 3.75M | $132.71M |
Erasca, Inc. | ERAS | 5.25M | $96.18M |